Truncated secretory aspartyl proteinase 2
US9610334B2 · kind B2 · utility
0Cited by
4References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 19, 2014 |
| Grant date | Apr 4, 2017 |
| Priority date | — |
| Expiry date | Mar 19, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an isolated truncated form of the secretory aspartyl proteinase 2, as well as to nucleic acid molecules encoding same. The present invention also relates to a composition comprising an isolated truncated form of the secretory aspartyl proteinase 2, as well as to nucleic acid molecules encoding same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.